Aclaris Therapeutics, Inc.
ACRS
$6.18
$0.162.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 91.56M | 105.42M | 90.75M | 95.91M | 99.81M |
| Total Receivables | 6.21M | 4.81M | 5.57M | 4.68M | 194.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | 4.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 97.77M | 110.23M | 96.32M | 100.59M | 104.20M |
|
|
|||||
| Total Current Assets | 97.77M | 110.23M | 96.32M | 100.59M | 104.20M |
| Net Property, Plant & Equipment | 2.65M | 2.89M | 3.05M | 3.24M | 3.44M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 212.00K | 231.00K | 486.00K | 406.00K | 424.00K |
| Total Assets | 179.69M | 198.72M | 160.46M | 175.53M | 189.15M |
|
|
|||||
| Total Accounts Payable | 15.52M | 14.73M | 13.16M | 9.19M | 8.80M |
| Total Accrued Expenses | 4.59M | 4.53M | 7.41M | 5.83M | 4.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 588.00K | 569.00K | 551.00K | 533.00K | 515.00K |
| Total Finance Division Other Current Liabilities | 7.55M | 7.54M | 7.52M | 10.08M | 12.68M |
| Total Other Current Liabilities | 7.55M | 7.54M | 7.52M | 10.08M | 12.68M |
| Total Current Liabilities | 28.24M | 27.37M | 28.65M | 25.63M | 26.84M |
|
|
|||||
| Total Current Liabilities | 28.24M | 27.37M | 28.65M | 25.63M | 26.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.26M | 1.42M | 1.57M | 1.71M | 1.85M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.61M | 26.29M | 27.17M | 28.09M | 28.72M |
| Total Liabilities | 55.11M | 55.07M | 57.38M | 55.43M | 57.41M |
|
|
|||||
| Common Stock & APIC | 1.13B | 1.13B | 1.07B | 1.07B | 1.06B |
| Retained Earnings | -1.01B | -987.61M | -967.78M | -947.99M | -933.38M |
| Treasury Stock & Other | -304.00K | 22.00K | 610.00K | 597.00K | 482.00K |
| Total Common Equity | 124.58M | 143.65M | 103.08M | 120.10M | 131.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 124.58M | 143.65M | 103.08M | 120.10M | 131.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 124.58M | 143.65M | 103.08M | 120.10M | 131.74M |
|
|
|||||